European Union -
English -
EMA (European Medicines Agency)
scemblix
novartis europharm limited - asciminib hydrochloride - leukemia, myelogenous, chronic, bcr-abl positive - antineoplastic agents - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.1).
Singapore -
English -
HSA (Health Sciences Authority)
scemblix film-coated tablet 20 mg
novartis (singapore) pte ltd - asciminib hydrochloride eqv asciminib - tablet, film coated - asciminib hydrochloride eqv asciminib 20mg
Singapore -
English -
HSA (Health Sciences Authority)
scemblix film-coated tablet 40 mg
novartis (singapore) pte ltd - asciminib hydrochloride eqv asciminib - tablet, film coated - asciminib hydrochloride eqv asciminib 40 mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
asciminib 40mg tablets
novartis pharmaceuticals uk ltd - asciminib hydrochloride - oral tablet - 40mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
asciminib 20mg tablets
novartis pharmaceuticals uk ltd - asciminib hydrochloride - oral tablet - 20mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
scemblix 20mg tablets
novartis pharmaceuticals uk ltd - asciminib hydrochloride - tablet - 20mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
scemblix 40mg tablets
novartis pharmaceuticals uk ltd - asciminib hydrochloride - tablet - 40mg
Canada -
English -
Health Canada
scemblix tablet
novartis pharmaceuticals canada inc - asciminib (asciminib hydrochloride) - tablet - 20mg - asciminib (asciminib hydrochloride) 20mg
Canada -
English -
Health Canada
scemblix tablet
novartis pharmaceuticals canada inc - asciminib (asciminib hydrochloride) - tablet - 40mg - asciminib (asciminib hydrochloride) 40mg
Israel -
English -
Ministry of Health
scemblix 20 mg
novartis israel ltd - asciminib as hydrochloride - film coated tablets - asciminib as hydrochloride 20 mg - asciminib - scemblix is indicated for the treatment of adult patients with:• philadelphia chromosome-positive chronic myeloid leukemia (ph+ cml) in chronic phase (cp), previously treated with two or more tyrosine kinase inhibitors (tkis).• ph+ cml in cp with the t315i mutation